Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 4 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway.
Lipids Health Dis. 2023 Nov 18;22(1):198. doi: 10.1186/s12944-023-01949-2.
Lipids Health Dis. 2023.
PMID: 37978497
Free PMC article.
Associations between abdominal obesity indices and pathological features of non-alcoholic fatty liver disease: Chinese visceral adiposity index.
Li R, Liu J, Han P, Shi R, Zhao L, Li J.
Li R, et al.
J Gastroenterol Hepatol. 2023 Aug;38(8):1316-1324. doi: 10.1111/jgh.16196. Epub 2023 Apr 26.
J Gastroenterol Hepatol. 2023.
PMID: 37102199
Item in Clipboard
Hedan tablet ameliorated non-alcoholic steatohepatitis by moderating NF-κB and lipid metabolism-related pathways via regulating hepatic metabolites.
Guo L, Lei J, Li P, Wang Y, Wang J, Song T, Zhu B, Jia J, Miao J, Cui H.
Guo L, et al.
J Cell Mol Med. 2024 Apr;28(7):e18194. doi: 10.1111/jcmm.18194.
J Cell Mol Med. 2024.
PMID: 38506086
Free article.
Item in Clipboard
[Liver fibrosis screening, evaluation pathway, and management in patients with fatty liver].
Xu L, Mi YQ.
Xu L, et al.
Zhonghua Gan Zang Bing Za Zhi. 2023 Aug 20;31(8):798-804. doi: 10.3760/cma.j.cn501113-20230807-00036.
Zhonghua Gan Zang Bing Za Zhi. 2023.
PMID: 37723060
Review.
Chinese.
Item in Clipboard
Unveiling global research trends and hotspots on mitochondria in NAFLD from 2000 to 2023: A bibliometric analysis.
Hu J, Chen Z, Zhou Y, Li Y, Liu J, Mi Y, Wang L, Jiang F, Li P.
Hu J, et al.
Immun Inflamm Dis. 2024 Mar;12(3):e1226. doi: 10.1002/iid3.1226.
Immun Inflamm Dis. 2024.
PMID: 38533910
Free PMC article.
Item in Clipboard
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma.
Han J, Kuai W, Yang L, Tao X, Wang Y, Zeng M, Li Y, Mi Y, Zhang N, Lu W, Xu L.
Han J, et al.
Cancer Biol Med. 2024 May 6:j.issn.2095-3941.2024.0048. doi: 10.20892/j.issn.2095-3941.2024.0048. Online ahead of print.
Cancer Biol Med. 2024.
PMID: 38712819
Item in Clipboard
Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
Chen L, Tao X, Zeng M, Li Y, Han J, Wang Y, Liu Y, Shi R, Su R, Xu L, Mi Y.
Chen L, et al.
J Med Virol. 2024 Apr;96(4):e29613. doi: 10.1002/jmv.29613.
J Med Virol. 2024.
PMID: 38634477
Item in Clipboard
Cite
Cite